Premenstrual disorders

被引:142
作者
Yonkers, Kimberly Ann [1 ,2 ,3 ]
Simoni, Michael K. [2 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
menstrual cycle; premenstrual disorder; premenstrual dysphoric disorder; premenstrual symptoms; premenstrual syndrome; premenstrual tension; PHASE SERTRALINE TREATMENT; DYSPHORIC DISORDER; MENSTRUAL-CYCLE; ALLOPREGNANOLONE LEVELS; DOUBLE-BLIND; WOMEN; EFFICACY; SYMPTOMS; PREVALENCE; PLACEBO;
D O I
10.1016/j.ajog.2017.05.045
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Premenstrual disorders include premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual worsening of another medical condition. While the underlying causes of these conditions continue to be explored, an aberrant response to hormonal fluctuations that occurs with the natural menstrual cycle and serotonin deficits have both been implicated. A careful medical history and daily symptom monitoring across 2 menstrual cycles is important in establishing a diagnosis. Many treatments have been evaluated for the management of premenstrual disorders. The most efficacious treatments for premenstrual syndrome and premenstrual dysphoric disorder include serotonin reuptake inhibitors and contraceptives with shortened to no hormone-free interval. Women who do not respond to these and other interventions may benefit from gonadotropin-releasing hormone agonist treatment.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 74 条
  • [1] [Anonymous], COCHRANE DATABASE SY
  • [2] [Anonymous], BJOG
  • [3] [Anonymous], COCHRANE DATABASE SY
  • [4] [Anonymous], AM J PSYCHIAT 0421
  • [5] PARADOXICAL EFFECTS OF GABA-A MODULATORS MAY EXPLAIN SEX STEROID INDUCED NEGATIVE MOOD SYMPTOMS IN SOME PERSONS
    Backstrom, T.
    Haage, D.
    Lofgren, M.
    Johansson, I. M.
    Stromberg, J.
    Nyberg, S.
    Andreen, L.
    Ossewaarde, L.
    van Wingen, G. A.
    Turkmen, S.
    Bengtsson, S. K.
    [J]. NEUROSCIENCE, 2011, 191 : 46 - 54
  • [6] Abnormalities of Dorsolateral Prefrontal Function in Women With Premenstrual Dysphoric Disorder: A Multimodal Neuroimaging Study
    Baller, Erica B.
    Wei, Shau-Ming
    Kohn, Philip D.
    Rubinow, David R.
    Alarcon, Gabriela
    Schmidt, Peter J.
    Berman, Karen F.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (03) : 305 - 314
  • [7] Early Life Emotional, Physical, and Sexual Abuse and the Development of Premenstrual Syndrome: A Longitudinal Study
    Bertone-Johnson, Elizabeth R.
    Whitcomb, Brian W.
    Missmer, Stacey A.
    Manson, JoAnn E.
    Hankinson, Susan E.
    Rich-Edwards, Janet W.
    [J]. JOURNAL OF WOMENS HEALTH, 2014, 23 (09) : 729 - 739
  • [8] Adiposity and the Development of Premenstrual Syndrome
    Bertone-Johnson, Elizabeth R.
    Hankinson, Susan E.
    Willett, Walter C.
    Johnson, Susan R.
    Manson, JoAnn E.
    [J]. JOURNAL OF WOMENS HEALTH, 2010, 19 (11) : 1955 - 1962
  • [9] Diverse actions of ovarian steroids in the serotonin neural system
    Bethea, CL
    Lu, NZ
    Gundlah, C
    Streicher, JM
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 2002, 23 (01) : 41 - 100
  • [10] Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial
    Bixo, Marie
    Ekberg, Karin
    Poromaa, Inger Sundstrom
    Hirschberg, Angelica Linden
    Jonasson, Aino Fianu
    Andreen, Lotta
    Timby, Erika
    Wulff, Marianne
    Ehrenborg, Agneta
    Backstrom, Torbjorn
    [J]. PSYCHONEUROENDOCRINOLOGY, 2017, 80 : 46 - 55